Updated New Zealand cardiovascular disease risk-benefit prediction guide
- PMID: 10710588
- PMCID: PMC1117717
- DOI: 10.1136/bmj.320.7236.709
Updated New Zealand cardiovascular disease risk-benefit prediction guide
Erratum in
- BMJ 2000 Dec 9;321(7274):1454
Comment in
-
Guidelines on preventing cardiovascular disease in clinical practice.BMJ. 2000 Mar 11;320(7236):659-61. doi: 10.1136/bmj.320.7236.659. BMJ. 2000. PMID: 10710556 Free PMC article. No abstract available.
References
-
- MacMahon S, Rogers A. The effects of antihypertensive treatment on vascular disease: re-appraisal of the evidence in 1993. J Vasc Med Biol. 1993;4:265–271.
-
- West of Scotland Coronary Prevention Group. West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet. 1996;348:1339–1342. - PubMed
-
- National Health Committee. Guidelines for the management of mildly raised blood pressure in New Zealand. Wellington: Ministry of Health; 1995.
-
- Dyslipidaemia Advisory Group. 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. NZ Med J. 1996;109:224–232. - PubMed
-
- Anderson KV, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293–298. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources